Quote:
Originally Posted by gatefire08 
hopefully you guys didnt buy in....
Cardium Reports on Exchange Listing With NYSE AMEX
PR Newswire
SAN DIEGO, Jan. 4
SAN DIEGO /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) reported that it received notification from the staff of the company’s current listing exchange indicating that the company is currently considered to be noncompliant with certain listing requirements of the NYSE AMEX LLC. Based on the company's quarterly report on Form 10-Q, which was filed on , noncompliance was noted with respect to the requirements for minimum stockholders' equity under section 1003(a)(i) of the exchange’s company guide with stockholders’ equity of less than $2,000,000 and losses from continuing operations and net losses in two of its three most recent fiscal years and section 1003(a)(ii) of the exchange’s company guide with stockholders’ equity of less than $4,000,000 and losses from continuing operations and net losses in three of its four most recent fiscal years.
|
Last Update: 1/4/2010 5:57:00 PM
Cardium Reports on Exchange Listing With NYSE AMEX
SAN DIEGO, Jan 04, 2010 /PRNewswire-FirstCall via COMTEX/ -- Cardium Therapeutics (CXM) reported that it received notification from the staff of the company's current listing exchange indicating that the company is currently considered to be noncompliant with certain listing requirements of the NYSE AMEX LLC. Based on the company's quarterly report on Form 10-Q, which was filed on November 9, 2009, noncompliance was noted with respect to the requirements for minimum stockholders' equity under section 1003(a)(i) of the exchange's company guide with stockholders' equity of less than $2,000,000 and losses from continuing operations and net losses in two of its three most recent fiscal years and section 1003(a)(ii) of the exchange's company guide with stockholders' equity of less than $4,000,000 and losses from continuing operations and net losses in three of its four most recent fiscal years.
The company previously reported that it received a notification from NYSE AMEX LLC on December 23, 2008 that the company was considered to be noncompliant with certain of the exchange's listing requirements. On January 22, 2009, the company proposed a plan to the exchange to regain compliance with the listing requirements. On February 17, 2009, the exchange accepted the company's plan and, on July 24, 2009, the exchange advised the company that it had regained compliance with the minimum listing requirements. However, the exchange indicated that the compliance plan would remain open until the company demonstrated compliance with the exchange's continued listing standards for two consecutive quarters.
The notification received from NYSE AMEX LLC has no current effect on the listing of the company's shares on the exchange. Rather, the company has been afforded the opportunity to submit a supplement to the compliance plan the company first submitted to the exchange on January 22, 2009, pursuant to which the company would establish compliance with the requirements of section 1003(a)(i) and 1003(a)(ii) by June 23, 2010.
The company must submit the supplement to the compliance plan to the exchange by January 27, 2010. If the company does not submit an acceptable supplement to the compliance plan to the exchange or does not ultimately reestablish compliance within the required timeframes, then the exchange would be expected to initiate delisting proceedings. If the company's common stock was ultimately delisted from the exchange, it would be expected to trade on the OTC Bulletin Board, a regulated quotation service that provides quotes, sale prices and volume information in over-the-counter equity securities. The company's common stock was traded on the OTC Bulletin Board until July 2007, when the company elected to instead list its shares on the American Stock Exchange.